Wockhardt Limited has informed the Exchange regarding a press release dated January 02, 2025, titled "Indian Drug Regulator Approves Wockhardt's New Generation Oral Antibiotic Miqnaf? (Nafithromycin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)."